RecruitingNot ApplicableNCT07051109

Dual-chamber Patient-controlled Analgesia for Postoperative Recovery

Comparison of Postoperative Recovery Between Dual-channel Pump for Intravenous Patient-controlled Analgesia(IV-PCA) and Conventional Single-channel Pump After Laparoscopic Sleeve Gastrectomy: a Prospective Randomized Controlled Trial

Sponsor

Seoul National University Bundang Hospital

Enrollment

92 participants

Start Date

Oct 11, 2022

Study Type

INTERVENTIONAL

Conditions

Analgesia PCA Morbid Obesity PONV

Summary

Postoperative nausea and vomiting (PONV) are the most common complications that can occur after general anesthesia. Postoperative use of opioids and morbid obesity have been reported as risk factors of PONV. In this study, the investigators aimed to compare the degree of postoperative side effects and pain control when an intravenous patient-controlled analgesia combining fentanyl and ketorolac via a dual-chamber device was provided to participants undergoing laparoscopic sleeve gastrectomy.

Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called multimodal analgesia via dual-chamber PCA and a medical device called single regimen (only fentanyl) for people with analgesia, morbid obesity, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 19 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.